Browse > Article
http://dx.doi.org/10.4046/trd.2009.66.5.380

A Case of Docetaxel Induced Subacute Cutaneous Lupus Erythematosus  

Shin, Jung Ar (Department of Internal Medicine, Yonsei University College of Medicine)
Huh, Chul Woong (Department of Internal Medicine, Yonsei University College of Medicine)
Kwon, Ji Eun (Department of Pathology, Yonsei University College of Medicine)
Kim, Hyung Jung (Department of Internal Medicine, Yonsei University College of Medicine)
Ahn, Chul Min (Department of Internal Medicine, Yonsei University College of Medicine)
Chang, Yoon Soo (Department of Internal Medicine, Yonsei University College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.66, no.5, 2009 , pp. 380-384 More about this Journal
Abstract
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is associated with use of the following classes of medications: anti-hypertensives, anti-cholesterolemia, anti-psychotics, and anti-inflammatory drugs. Docetaxel is an anti-neoplastic agent, which is widely used for treatment of non-small cell lung cancer. Few cases of docetaxel-induced SCLE have been reported in the medical literature. Here, we report the case of a 58-year-old female patient who developed drug-induced SCLE after administration of docetaxel. After 4 cycles of chemotherapy with docetaxel and cisplatin, erythematous skin eruptions developed on the patient's face. Skin biopsies of the eruptions were remarkable for interfacing dermatitis with basement membrane thickening. Immunofluorescent study revealed characteristic features of SCLE, including granular deposition of IgM, C3, and apoptotic bodies along the basement membrane. The skin eruptions resolved gradually after cessation of drug and with the use of topical corticosteroids.
Keywords
Subacute cutaneous lupus erythematosus; Drug-induced lupus erythematosus; Non-small-cell lung carcinoma; Docetaxel;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Sontheimer RD, Henderson CL, Grau RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 2009;301:65-70   DOI   ScienceOn
2 Uetrecht J. Current trends in drug-induced autoimmunity. Autoimmun Rev 2005;4:309-14   DOI   PUBMED   ScienceOn
3 Stollar BD, Stephenson F. Apoptosis and nucleosomes. Lupus 2002;11:787-9   DOI   ScienceOn
4 Vasoo S. Drug-induced lupus: an update. Lupus 2006;15:757-61   DOI   PUBMED   ScienceOn
5 Dasanu CA, Alexandrescu DT. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer. South Med J 2008;101:1161-2   DOI   PUBMED   ScienceOn
6 Kretz-Rommel A, Rubin RL. Disruption of positive selection of thymocytes causes autoimmunity. Nat Med 2000;6:298-305   DOI   ScienceOn
7 Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res 2009;301:99-105   DOI   ScienceOn
8 Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000;58:207-16   DOI   PUBMED
9 Chen M, Crowson AN, Woofter M, Luca MB, Magro CM. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol 2004;31:818-20   PUBMED
10 Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 2001;28:1-23   DOI   ScienceOn
11 Rubin RL. Drug-induced lupus. Toxicology 2005;209:135-47   DOI   PUBMED   ScienceOn